Status | Study |
Recruiting |
Study Name: PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome Condition: Nervous System Disease Date: 2016-04-15 Interventions: Other: PET Other: MRI |
Completed |
Study Name: TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE Condition: Fibrous Dysplasia of Bone Date: 2013-02-13 Interventions: Drug: Tocilizumab 8 mg/kg/mont |
Completed |
Study Name: Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone Condition: Fibrous Dysplasia of Bone Date: 2007-03-08 Interventions: Drug: risedronate During two m |
Recruiting |
Study Name: Histamine Responsiveness in McCune-Albright Syndrome Condition: McCune-Albright Syndrome Date: 2006-04-24 |
Active, not recruiting |
Study Name: Faslodex in McCune Albright Syndrome Condition: Puberty, Precocious McCune-Albright Syndrome Date: 2006-01-17 Interventions: Drug: Fulvestrant intramuscular injection Other Name |
Completed |
Study Name: Arimidex in McCune Albright Syndrome Condition: McCune-Albright Syndrome Date: 2003-02-25 Interventions: Drug: Arimidex 1 mg Arimidex (anastrozole) 1mg once daily by mouth |
Completed |
Study Name: A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome Condition: McCune Albright Syndrome Polyostotic Fibr Date: 2001-06-20 Interventions: Drug: Pegvisomant |
Completed |
Study Name: Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome Condition: McCune Albright Syndrome Polyostotic Fibr Date: 2000-08-11 Interventions: Drug: Letrozole |
Completed |
Study Name: Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome Condition: Polyostotic Fibrous Dysplasia Date: 2000-01-18 |
Recruiting |
Study Name: Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome Condition: McCune Albright Syndrome Date: 1999-11-03 |